WasherCap™ ACL Fixation System
ACL Reconstruction (Soft-tissue graft fixation)
Key Facts
About ABANZA
ABANZA is a private, commercial-stage medical device company pioneering next-generation soft tissue fixation technologies for orthopedic and sports medicine applications. Founded in 2019, the company has developed a portfolio of implant systems, including QuadLock™ and WasherCap™, engineered to deliver stable fixation independent of bone quality, addressing a key clinical challenge in ligament reconstruction and repair. With a seasoned leadership team and a focus on the global sports medicine market, ABANZA is actively commercializing its products and establishing itself as an innovator in a competitive segment dominated by large orthopedics players. The company appears to be in an early revenue phase, leveraging a direct and distributor-based commercial model to drive adoption.
View full company profileTherapeutic Areas
Other ACL Reconstruction (Soft-tissue graft fixation) Drugs
| Drug | Company | Phase |
|---|---|---|
| QuadLock™ ACL System | ABANZA | Commercial |